Latest News in the pharma Industry
Research & Development
Achelios Therapeutics concludes successful Type C meeting with FDA regarding Topofen
14 Jun 2017
Currently there are no approved topical NSAIDs indicated for the treatment of migraine.
Read more
Lilly's galcanezumab significantly reduces number of migraine headache days
12 Jun 2017
New results presented at AHS.
Read more
Lilly announces strategic collaboration with KeyBioscience
8 Jun 2017
Collaboration to focus on a potential new class of treatments for metabolic disorders.
Read more
FDA Advisory Committee to review Avastin biosimilar candidate
7 Jun 2017
The Committee will review analytical, pharmacokinetic and clinical data from studies involving ABP 215, including results from a Phase III study in patients with NSCLC.
Read more
New BMS collaboration to evaluate combination therapy in colorectal cancer
6 Jun 2017
Phase I/II study to evaluate the combination of Opdivo (nivolumab) and Opdivo +Yervoy (ipilimumab) regimen with Mekinist (trametinib) in patients with colorectal cancer.
Read more
Combination therapy shown to shrink tumours in many patients whose cancer has spread to the brain
5 Jun 2017
Combination of nivolumab plus ipilimumab can fundamentally change survival expectations.
Read more
Spinraza approved in the EU as first treatment for spinal muscular atrophy
2 Jun 2017
Robust data from Phase III studies demonstrated positive impact on motor milestone achievement; increased survival in infants with SMA.
Read more
NICE approves first use of Opdivo in blood cancer
2 Jun 2017
NICE has recommended immunotherapy drug nivolumab for the treatment of adult patients with classical Hodgkin lymphoma.
Read more
NIH researchers find potential genetic cause of Cushing syndrome
1 Jun 2017
Finding may lead to therapies that prevent pituitary tumor recurrence.
Read more
Hookipa Biotech announces data showing TheraT turns cold tumours hot
30 May 2017
TheraT mediated alarmin release crucial for active immunization in cancer immunotherapy.
Read more
FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma
26 May 2017
Application is based on results from the Phase I/II CheckMate -040 trial.
Read more
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study
26 May 2017
Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.
Read more